[KYMR] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -36.26%
YoY- -22.94%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 25,650 10,287 47,885 4,728 16,513 9,466 16,139 36.22%
PBT -42,062 -48,557 -14,368 -52,867 -38,799 -40,928 -34,865 13.33%
Tax 0 39 4,996 -895 4,632 -4,343 -818 -
NP -42,062 -48,557 -14,368 -52,867 -38,799 -36,585 -34,047 15.14%
Tax Rate - - - - - - - -
Total Cost 67,712 58,844 62,253 57,595 55,312 46,051 50,186 22.12%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -163.98 -472.02 -30.01 -1,118.17 -234.96 -386.49 -210.96 -15.47%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -1.13%
EPS Diluted -0.58 -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -1.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.